Related Experiment Videos
Group B streptococci in neonatal deaths
Applied Microbiology
|June 1, 1969
Abstract:
Clinical microbiologists are reminded to look for group B streptococci in neonatal infants. We report four deaths, one with meningitis, occurring among 14 such infected newborn infants at our institution; of the nursing staff, 31% were also carriers of group B streptococci.
Insights
Clinical microbiologists should screen for group B streptococci in newborns. This bacterium caused four infant deaths, including meningitis, and 31% of nursing staff were carriers.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Clinical Microbiology
Background:
- Group B Streptococcus (GBS) is a significant pathogen in neonatal infections.
- Early identification and management are crucial for improving infant outcomes.
Purpose of the Study:
- To highlight the importance of GBS screening in neonatal infants.
- To report on a series of GBS infections in newborns at a single institution.
Main Methods:
- Retrospective review of neonatal infants diagnosed with GBS infection.
- Assessment of GBS carrier status among nursing staff.
Main Results:
- Four deaths occurred among 14 infected neonatal infants.
- One of the deaths was attributed to GBS meningitis.
- A high carrier rate of 31% was observed among the nursing staff.
Conclusions:
- Group B Streptococcus poses a severe risk to neonatal health, necessitating vigilant clinical microbiology practices.
- The findings underscore the need for robust screening protocols to prevent GBS-related mortality and morbidity in newborns.